(Q37485088)

20 August 2017

0 references

Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity (English)

1 reference

20 August 2017

0 references

0 references

Camila Manrique

1

1 reference

20 August 2017

Megan Johnson

series ordinal

2

1 reference

20 August 2017

James R Sowers

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

16 November 2009

1 reference

20 August 2017

1 reference

20 August 2017

55

1 reference

20 August 2017

1

1 reference

20 August 2017

15-17

1 reference

Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Realities of newer beta-blockers for the management of hypertension

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Metabolic syndrome and incident diabetes: current state of the evidence

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Risk factor assessment for new onset diabetes: literature review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Effect of antihypertensive agents on the development of type 2 diabetes mellitus

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796286

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19917873

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19917873

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1161/HYPERTENSIONAHA.109.142620

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19917873

1 reference